NCT04009044View on ClinicalTrials.gov

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

February 17, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

June 25, 2026

Conditions

Cancer SurvivorDuctal Breast Carcinoma In SituInvasive Breast Carcinoma

Interventions

DRUG

Afimoxifene

Apply topically

PROCEDURE

Core Biopsy

Undergo core needle biopsy

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (2)

60611

Northwestern University, Chicago

60612

University of Illinois Cancer Center, Chicago

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT04009044 - Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast | Biotech Hunter | Biotech Hunter